The shape of a molecule influences
its properties. While this is true on a per-compound level, things get a little
more controversial when discussing molecules in general. Back in 2009
researchers argued that “three dimensional” molecules have better drug-like
properties, though this assertion has been challenged, repeatedly. But how do
you assess the shape of a molecule in the first place? In a recent (open-access) Drug
Discov. Today paper, Iwan de Esch and
collaborators at Vrije Universiteit Amsterdam compare the main metrics.
The researchers focus on three metrics:
fraction of sp3-hybridized carbons (FCsp3),
which we wrote about here; plane of best fit (PBF), which we wrote about here;
and principal moment of inertia (PMI), which we wrote about here. FCsp3,
which ranges from 0 to 1, is simple to calculate based on the chemical
structure alone, while the other two metrics rely on the three-dimensional
shape of the molecule, requiring calculations and indeed choices since many
molecules can assume multiple conformations. PBF is measured in angstroms with
a minimum of 0 Å and no maximum; a protein, for example, could easily have a
PBF above 10 Å. PMI is represented by two normalized PMI ratios, and these are
often added to give a number (3D Score or ΣNPR) between 1 and 2.
The researchers calculated FCsp3,
PBF, and ΣNPR for a set of nearly half a million commercially available
fragments which we discussed here; PBF and ΣNPR were calculated based on the
single lowest energy conformation for each molecule. As noted above, PBF is somewhat
size-dependent. For example, adamantane and buckminsterfullerene have PBF scores
of 0.79 and 1.76 Å but identical ΣNPR scores. Nonetheless, the researchers found
a correlation between these two metrics, and this correlation increased when
PBF was divided by the root of the molecular volume to attempt to normalize for
size.
In contrast, no correlation was
found between FCsp3 and PMI, making the former “a poor
descriptor for predicting 3D molecular shape.” Is there a simple alternative? FCsp3
only considers carbon atoms, so the researchers proposed FHAsp3,
which includes nitrogen, oxygen, and sulfur atoms. Perhaps not surprisingly,
this didn’t improve the correlation.
Three years ago we wrote about “spacial scores,” which were developed to assess molecular complexity. The researchers
calculated normalized spacial scores (nSPS) for their set of compounds, but
these also showed no correlation to PMI.
The researchers conclude that, “once
corrected for size, PBF captures three-dimensionality similarly to ΣNPR values.
However, unlike a PMI analysis, it is not capable of further distinguishing between
rod- and disc-shaped molecules, giving PMI a higher resolution in capturing
shape diversity.” Interestingly, this is the opposite conclusion of an analysis
Teddy wrote about in 2014. My take is that, if you want to assess shapeliness, steer
clear of FCsp3, but both PBF and PMI are fine.
No comments:
Post a Comment